Regarding the migration of effector CD4+ T cells, no significant difference was found before and after specifically blocking p-VASP (Ser 157) in healthy individuals, untreated RA patients, and RA patients treated with IL-6 receptor blockade (Fig. 5d). The gene discussed is VASP; the disease is rheumatoid arthritis.